CN110114067A - 3-羟基丁酸甘油酯用于创伤性脑损伤 - Google Patents

3-羟基丁酸甘油酯用于创伤性脑损伤 Download PDF

Info

Publication number
CN110114067A
CN110114067A CN201780080457.XA CN201780080457A CN110114067A CN 110114067 A CN110114067 A CN 110114067A CN 201780080457 A CN201780080457 A CN 201780080457A CN 110114067 A CN110114067 A CN 110114067A
Authority
CN
China
Prior art keywords
hydroxybutyrate
glyceride
tbi
administration
fatty acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780080457.XA
Other languages
English (en)
Chinese (zh)
Inventor
萨米·哈希姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuroenergy Ventures Inc
Original Assignee
Neuroenergy Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroenergy Ventures Inc filed Critical Neuroenergy Ventures Inc
Publication of CN110114067A publication Critical patent/CN110114067A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201780080457.XA 2017-01-12 2017-11-30 3-羟基丁酸甘油酯用于创伤性脑损伤 Pending CN110114067A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/404,396 2017-01-12
US15/404,396 US9925164B1 (en) 2017-01-12 2017-01-12 Glyceryl 3-hydroxybutyrates for traumatic brain injury
PCT/US2017/063853 WO2018132189A1 (en) 2017-01-12 2017-11-30 Glyceryl 3-hydroxybutyrates for traumatic brain injury

Publications (1)

Publication Number Publication Date
CN110114067A true CN110114067A (zh) 2019-08-09

Family

ID=61633011

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780080457.XA Pending CN110114067A (zh) 2017-01-12 2017-11-30 3-羟基丁酸甘油酯用于创伤性脑损伤

Country Status (11)

Country Link
US (3) US9925164B1 (cg-RX-API-DMAC7.html)
EP (1) EP3568129A4 (cg-RX-API-DMAC7.html)
JP (1) JP7278593B2 (cg-RX-API-DMAC7.html)
KR (1) KR102443942B1 (cg-RX-API-DMAC7.html)
CN (1) CN110114067A (cg-RX-API-DMAC7.html)
BR (1) BR112019014128A2 (cg-RX-API-DMAC7.html)
CA (1) CA3046355C (cg-RX-API-DMAC7.html)
IL (1) IL267934B2 (cg-RX-API-DMAC7.html)
MX (1) MX391851B (cg-RX-API-DMAC7.html)
MY (1) MY207193A (cg-RX-API-DMAC7.html)
WO (1) WO2018132189A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116113617A (zh) * 2020-07-13 2023-05-12 Ioi油脂化学品有限责任公司 氧代丁醇酯化的多元羧酸聚甘油酯的制备方法

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12521378B2 (en) 2016-04-19 2026-01-13 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US12533346B2 (en) 2016-04-19 2026-01-27 Axcess Global Sciences, Llc Administration of berberine metabolites
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US20230346721A1 (en) 2018-04-18 2023-11-02 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12599579B2 (en) 2016-04-19 2026-04-14 Axcess Global Sciences, Llc Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids
SG11201809211QA (en) * 2016-04-19 2018-11-29 Keto Patent Group Inc Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US11026929B2 (en) 2016-04-19 2021-06-08 Keto Patent Group, Inc. Administration of berberine metabolites
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12622889B2 (en) 2016-04-19 2026-05-12 Axcess Global Sciences, Llc S-β-hydroxybutyrate esters for improving metabolic function
US10376528B2 (en) 2017-03-10 2019-08-13 Tecton Group, Llc Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
US12171735B2 (en) 2017-04-19 2024-12-24 Axcess Global Sciences, Llc Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
GB201715654D0 (en) 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
WO2020147978A1 (de) * 2019-01-17 2020-07-23 Ioi Oleo Gmbh Verfahren zur herstellung von glyceriden von hydroxycarbonsäuren
ES2965646T3 (es) * 2019-01-17 2024-04-16 Ketolipix Therapeutics Gmbh Procedimiento para la producción de lípidos que contienen unidades estructurales a base de glicéridos de ácidos hidroxicarboxílicos
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
CN113710243A (zh) * 2019-05-30 2021-11-26 神经活力投资公司 甘油三(β-羟基丁酸酯)与神经元短暂性脑缺血发作
ES2969217T3 (es) * 2019-06-12 2024-05-17 Ketolipix Therapeutics Gmbh Procedimiento para la producción de ésteres a base de poliol, en particular ésteres de poliglicerol, de ácidos hidroxicarboxílicos
CN113966323B (zh) * 2019-06-12 2023-11-28 凯托利皮克斯治疗有限责任公司 一种用于生产酮羧酸多元醇基酯的方法
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2023283654A1 (en) * 2021-07-09 2023-01-12 Georgia State University Research Foundation, Inc. The use of beta-hydroxybutyrates for the treatment or prevention of aneurysms and dissections
AU2022387742A1 (en) 2021-11-12 2024-06-27 Arxada Ag Polyol-derived compounds
WO2023094654A1 (en) 2021-11-26 2023-06-01 Arxada Ag Acetoacetate based ketals
US12023382B2 (en) 2022-01-18 2024-07-02 Today Inc. Molecules, formulations, and methods for nutritional support of athletes, patients, and others
WO2023139357A1 (en) * 2022-01-18 2023-07-27 Today Inc. Molecules, nutritional formulations, and methods of providing nutritional support
US20230277484A1 (en) * 2022-03-04 2023-09-07 Guardian Biosciences, LLC Compositions and methods to promote brain health
EP4605371A1 (en) 2022-10-18 2025-08-27 Arxada AG Polyol-derived compounds
WO2025074001A2 (en) 2023-10-05 2025-04-10 Arxada Ag Enzymatic reduction of acetoacetate
WO2025196156A1 (en) 2024-03-20 2025-09-25 Arxada Ag Continuous hydrogenation process of acetoacetate esters
WO2025224319A1 (en) 2024-04-25 2025-10-30 Arxada Ag Reduction of acetoacetate esters in the presence of amines
WO2026090272A1 (en) * 2024-10-23 2026-04-30 2508 Biosciences Llc Methods and compositions for the treatment of disease

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008005818A1 (en) * 2006-06-30 2008-01-10 Stepan Co Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
WO2011101171A1 (en) * 2010-02-22 2011-08-25 Tdeltas Limited Nutritional composition
WO2015034812A2 (en) * 2013-09-04 2015-03-12 Beth Israel Deaconess Medical Center A new ketogenic diet and its use in treating the critically ill

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
CN1315473C (zh) * 1997-03-17 2007-05-16 英国技术集团国际有限公司 治疗组合物
US8124589B2 (en) 2000-05-01 2012-02-28 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
CN103505728A (zh) 2005-05-26 2014-01-15 科罗拉多大学评议会法人机构 用于治疗外伤性脑损伤、脊髓损伤及相关病症的补体旁路抑制
CA2684213A1 (en) 2007-04-12 2008-10-23 Regents Of The University Of Minnesota Ischemia/reperfusion protection compositions and methods of using
JP2009173766A (ja) 2008-01-24 2009-08-06 Ono Kogei Kk 炭素繊維含有コーティング組成物およびその調製方法
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
AU2010207597A1 (en) 2009-01-24 2011-08-18 Phytopharm Plc Treatment of neurotrophic factor mediated disorders
CA2873057C (en) 2011-05-09 2020-02-25 University Of South Florida The use of ketone esters for prevention of cns oxygen toxicity
US20140072654A1 (en) 2011-12-23 2014-03-13 Savind, Inc. Cancer with metabolic therapy and hyperbaric oxygen
FR2997302B1 (fr) 2012-10-29 2015-02-06 Assist Publ Hopitaux De Paris Prevention et traitement des deficits en pyruvate deshydrogenase
WO2014071389A1 (en) 2012-11-05 2014-05-08 Veech Richard L Ketone bodies to protect tissues from damage by ionizing radiation
EP2925308B1 (en) 2012-11-28 2019-12-25 University Of South Florida Targeting cancer with metabolic therapy and hyperbaric oxygen
BR112015024186B1 (pt) 2013-03-19 2023-05-09 University Of South Florida Composições e métodos para produção de cetose de elevação e manutenção
CA2973342A1 (en) 2014-01-13 2015-10-15 University Of South Florida Methods of sustaining dietary ketosis and its effects on lipid profile
US20160078782A1 (en) 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
US9364456B1 (en) 2015-06-30 2016-06-14 University Of South Florida Ketone esters for treatment of angelman syndrome
US20180200220A1 (en) 2015-07-10 2018-07-19 Cognate Nutritionals, Inc. Prophylaxis and mitigation of migraine headaches using ketogenic medium chain triglycerides, ketone esters, and other ketogenic sources
US10292952B2 (en) 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US20190091189A1 (en) 2016-03-21 2019-03-28 Csilla Ari D'Agostino Administration of exogenous ketone to lower blood glucose
US10376482B2 (en) 2016-04-03 2019-08-13 Franco Cavaleri Butyrate and beta-hydroxybutyrate compositions
SG11201809211QA (en) 2016-04-19 2018-11-29 Keto Patent Group Inc Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
WO2018009208A1 (en) 2016-07-08 2018-01-11 Cognate Nutritionals, Inc. Nutritional mitiggation of the cns effects of traumatic brain injury
US10588877B2 (en) 2016-07-21 2020-03-17 Savind, Inc. Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
US20180055797A1 (en) 2016-08-31 2018-03-01 KetoneAid Inc. Non-racemic ketone salts for rapid-onset nutritional ketosis and metabolic therapy
JP2019526607A (ja) 2016-09-12 2019-09-19 ユニバーシティ・オブ・サウス・フロリダ ケトンにより改善された神経再生

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008005818A1 (en) * 2006-06-30 2008-01-10 Stepan Co Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
WO2011101171A1 (en) * 2010-02-22 2011-08-25 Tdeltas Limited Nutritional composition
WO2015034812A2 (en) * 2013-09-04 2015-03-12 Beth Israel Deaconess Medical Center A new ketogenic diet and its use in treating the critically ill

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HAYDEN WHITE等: "Clinical review: Ketones and brain injury", 《CRITICAL CARE》 *
INSTITUTE OF MEDICINE COMMITTEE ON NUTRITION TRAUMA AND THE BRAI: "《Nutrition and Traumatic Brain Injury》", 30 November 2011 *
MACIEJ GASIORA等: "Neuroprotective and disease-modifying effects of the ketogenic diet", 《BEHAV PHARMACLO.》 *
MAYUMI L. PRINS等: "The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury", 《JOURNAL OF LIPID RESEARCH》 *
SAMI A. HASHIM等: "Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester", 《JOURNAL OF LIPID RESEARCH》 *
YANG SHUGUANG等: "Arachidonic acid: a bridge between traumatic brain injury and fracture healing", 《JOURNAL OF NEUROTRAUMA》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116113617A (zh) * 2020-07-13 2023-05-12 Ioi油脂化学品有限责任公司 氧代丁醇酯化的多元羧酸聚甘油酯的制备方法

Also Published As

Publication number Publication date
IL267934B1 (en) 2024-05-01
MY207193A (en) 2025-02-05
KR20190104546A (ko) 2019-09-10
JP7278593B2 (ja) 2023-05-22
JP2020504134A (ja) 2020-02-06
US9925164B1 (en) 2018-03-27
US11638702B2 (en) 2023-05-02
MX2019008269A (es) 2019-09-13
US10736867B2 (en) 2020-08-11
CA3046355C (en) 2023-08-01
IL267934B2 (en) 2024-09-01
KR102443942B1 (ko) 2022-09-15
IL267934A (en) 2019-09-26
WO2018132189A1 (en) 2018-07-19
EP3568129A4 (en) 2020-12-09
US20180193300A1 (en) 2018-07-12
CA3046355A1 (en) 2018-07-19
US20200297686A1 (en) 2020-09-24
MX391851B (es) 2025-03-21
BR112019014128A2 (pt) 2020-06-16
EP3568129A1 (en) 2019-11-20

Similar Documents

Publication Publication Date Title
US11638702B2 (en) Glyceryl 3-hydroxybutyrates for traumatic brain injury
Antushevich Fecal microbiota transplantation in disease therapy
JP7108320B2 (ja) 片頭痛の症状を管理するためのグリセリル3-ヒドロキシブチラート
JP2020504134A5 (cg-RX-API-DMAC7.html)
Hooper et al. Controversies and misconceptions in intensive care unit nutrition
Quintard et al. Nutritional and metabolic supplementation for the injured brain: an update
RS20050226A (sr) EIKOSAPENTAENOIČNA KISELINA (EPA) ZA LEČENjE ANOREXIA NERVOSA I BULIMIJE
JP7847432B2 (ja) 食後血糖応答を制御するための乳清タンパク質ミセルの使用
Lane et al. Ketogenic diet and health
Griffiths Specialized nutrition support in critically ill patients
Phillips Ketogenic diet therapies in children and adults with epilepsy
Kuźniar et al. Ketogenic diet and intermittent fasting-impact on body weight and various diseases
HK40012461A (en) Glyceryl 3-hydroxybutyrates for traumatic brain injury
CN109999044B (zh) 一种含有醉茄素a的组合物及其应用
JPWO2013005834A1 (ja) 高純度epaを含有する抗肥満剤
CN109908165B (zh) 一种含有雷公藤红素的组合物及其应用
JP2011241216A (ja) モズク由来のフコイダンを含む食品
Hu et al. Impact of zinc supplementation on the clinical outcomes in critically ill patients: A systematic review and meta-analysis
Górska et al. Apple Cider Vinegar in the Combat Against Type 2 Diabetes and Obesity–An Overview of Recent Research
Wei et al. Mucosal Immunity and Autoimmune Diseases: New Perspectives From Mechanisms to Treatment
Di Lorenzo et al. Position Paper on the Applications of Ketogenic Diets in Patients with Headache: Consensus Statement
Enns et al. Clinical outcomes of major clinical events and emergency triheptanoin use in critically ill patients with long-chain fatty acid oxidation disorders
WO2022115293A1 (en) Parenteral nutrition formulation comprising arginine butyrate
Egleston Common toxins in dogs
grief will become a Major MENTAL DISORDERS FOR EVERYONE

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40012461

Country of ref document: HK